Eli Lilly

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Eli Lilly 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About LLY

Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products include diabetes, oncology, immunology, neuroscience, and other products and therapies. 

CEO
David A. Ricks
CEODavid A. Ricks
Employees
50,000
Employees50,000
Headquarters
Indianapolis, Indiana
HeadquartersIndianapolis, Indiana
Founded
1876
Founded1876
Employees
50,000
Employees50,000

LLY Key Statistics

Market cap
1.06T
Market cap1.06T
Price-Earnings ratio
38.83
Price-Earnings ratio38.83
Dividend yield
0.60%
Dividend yield0.60%
Average volume
3.29M
Average volume3.29M
High today
$1,140.46
High today$1,140.46
Low today
$1,078.78
Low today$1,078.78
Open price
$1,111.25
Open price$1,111.25
Volume
2.61M
Volume2.61M
52 Week high
$1,149.10
52 Week high$1,149.10
52 Week low
$623.78
52 Week low$623.78

Stock Snapshot

With a market cap of 1.06T, Eli Lilly(LLY) trades at $1,123.89. The stock has a price-to-earnings ratio of 38.83 and currently yields dividends of 59.9%.

On 2026-06-04, Eli Lilly(LLY) stock moved within a range of $1,078.78 to $1,140.46. With shares now at $1,123.89, the stock is trading +4.2% above its intraday low and -1.5% below the session's peak.

Trading activity shows a volume of 2.61M, compared to an average daily volume of 3.29M.

Over the past 52 weeks, Eli Lilly(LLY) stock has traded between a high of $1,149.10 and a low of $623.78.

Over the past 52 weeks, Eli Lilly(LLY) stock has traded between a high of $1,149.10 and a low of $623.78.

LLY News

TipRanks 2h
Eli Lilly Stock Jumps on Major Drug Trial Wins - TipRanks

...

Eli Lilly Stock Jumps on Major Drug Trial Wins - TipRanks
TipRanks 3h
Lilly’s ATTAIN-MAINTAIN Trial: A Fresh Pill-Based Play in the Obesity Market

Eli Lilly And Company (LLY) announced an update on their ongoing clinical study. Unlock trusted, data-backed investing tools with TipRanks Premium, from analys...

Benzinga 3h
Weight Watchers Broadens GLP-1 Reach As Eli Lilly Pursues New Kidney Disease Therapies

• Eli Lilly stock is surging to new heights today. What’s driving LLY stock higher? Weight Watchers Expands GLP-1 Access Through LillyDirect The addition to L...

Weight Watchers Broadens GLP-1 Reach As Eli Lilly Pursues New Kidney Disease Therapies

Analyst ratings

85%

of 33 ratings
Buy
84.8%
Hold
9.1%
Sell
6.1%

More LLY News

Nasdaq 5h
Eli Lilly Sees More Dealmaking Ahead as Management Looks To Leverage Its GLP-1 Success

Key Points Eli Lilly's GLP-1 drugs Mounjaro and Zepbound are seeing massive demand. Like all drugs, Mounjaro and Zepbound have time-limited patent protections...

Eli Lilly Sees More Dealmaking Ahead as Management Looks To Leverage Its GLP-1 Success
Nasdaq 12h
Forget Weight Loss Drugs: Here Is Another Reason to Buy Eli Lilly Stock

Key Points Eli Lilly has worked hard to diversify its pipeline. Three new acquisitions will further help decrease its exposure to its core market. Eli Lilly'...

Forget Weight Loss Drugs: Here Is Another Reason to Buy Eli Lilly Stock
Benzinga 13h
Elizabeth Warren Singles Out Micron, Dell And Eli Lilly As Just 3 Of The 3000+ Trades Trump Made: 'Looks Like An Absurd Level Of Corruption'

Sen. Elizabeth Warren (D-Mass.) criticized President Donald Trump’s trading activity, arguing that the volume and timing of transactions in his investment portf...

Elizabeth Warren Singles Out Micron, Dell And Eli Lilly As Just 3 Of The 3000+ Trades Trump Made: 'Looks Like An Absurd Level Of Corruption'
Nasdaq 1d
Forget Zepbound: Eli Lilly's Next Billion-Dollar Weight-Loss Drug May Be Even Better

Key Points Eli Lilly's retatrutide seems even more effective than Zepbound. The drugmaker should continue riding the weight-loss tailwind. 10 stocks we like...

Forget Zepbound: Eli Lilly's Next Billion-Dollar Weight-Loss Drug May Be Even Better
Seeking Alpha 1d
Lilly halving planned €2.3B investment in Germany: CEO

Eli Lilly (LLY) CEO Dave Ricks told German business daily Handelsblatt that his company will halve its initially planned €2.3B ($2.7B) investment in Germany as...

Lilly halving planned €2.3B investment in Germany: CEO
TipRanks 1d
Lilly’s TRIUMPH-1 Retatrutide Trial Reaches Key Milestone in Obesity Drug Race

Eli Lilly And Company (LLY) announced an update on their ongoing clinical study. Unlock trusted, data-backed investing tools with TipRanks Premium, from analys...

24/7 Wall St. 1d
Move Over AI: Jeff Bezos and NVIDIA Are Quietly Backing a New Breakthrough Industry

The analyst who called NVIDIA in 2010 just named his top 10 stocks and Eli Lilly wasn't one of them. Get them here FREE . Over recent months, a striking patter...

Move Over AI: Jeff Bezos and NVIDIA Are Quietly Backing a New Breakthrough Industry

People also own

Based on the portfolios of people who own LLY. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.